203 related articles for article (PubMed ID: 21692988)
1. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression.
Cole J; Weinberger DR; Mattay VS; Cheng X; Toga AW; Thompson PM; Powell-Smith G; Cohen-Woods S; Simmons A; McGuffin P; Fu CH
Genes Brain Behav; 2011 Oct; 10(7):756-64. PubMed ID: 21692988
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
[TBL] [Abstract][Full Text] [Related]
3. The effects of 5-HTTLPR and BDNF Val66Met polymorphisms on neurostructural changes in major depressive disorder.
Han KM; Choi S; Kim A; Kang J; Won E; Tae WS; Kim YK; Lee MS; Ham BJ
Psychiatry Res Neuroimaging; 2018 Mar; 273():25-34. PubMed ID: 29414128
[TBL] [Abstract][Full Text] [Related]
4. BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields.
Frodl T; Skokauskas N; Frey EM; Morris D; Gill M; Carballedo A
Hum Brain Mapp; 2014 Dec; 35(12):5776-83. PubMed ID: 25044977
[TBL] [Abstract][Full Text] [Related]
5. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.
Cardoner N; Soria V; Gratacòs M; Hernández-Ribas R; Pujol J; López-Solà M; Deus J; Urretavizcaya M; Estivill X; Menchón JM; Soriano-Mas C
Depress Anxiety; 2013 Mar; 30(3):225-33. PubMed ID: 23165919
[TBL] [Abstract][Full Text] [Related]
6. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
[TBL] [Abstract][Full Text] [Related]
7. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
8. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
[TBL] [Abstract][Full Text] [Related]
9. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
Jaworska N; MacMaster FP; Foster J; Ramasubbu R
BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
[TBL] [Abstract][Full Text] [Related]
10. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
[TBL] [Abstract][Full Text] [Related]
11. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
[TBL] [Abstract][Full Text] [Related]
12. BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.
Fisher PM; Holst KK; Adamsen D; Klein AB; Frokjaer VG; Jensen PS; Svarer C; Gillings N; Baare WF; Mikkelsen JD; Knudsen GM
Hum Brain Mapp; 2015 Jan; 36(1):313-23. PubMed ID: 25220079
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume.
Carballedo A; Morris D; Zill P; Fahey C; Reinhold E; Meisenzahl E; Bondy B; Gill M; Möller HJ; Frodl T
Am J Med Genet B Neuropsychiatr Genet; 2013 Mar; 162B(2):183-90. PubMed ID: 23341118
[TBL] [Abstract][Full Text] [Related]
14. The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data.
Harrisberger F; Spalek K; Smieskova R; Schmidt A; Coynel D; Milnik A; Fastenrath M; Freytag V; Gschwind L; Walter A; Vogel T; Bendfeldt K; de Quervain DJ; Papassotiropoulos A; Borgwardt S
Neurosci Biobehav Rev; 2014 May; 42():267-78. PubMed ID: 24674929
[TBL] [Abstract][Full Text] [Related]
15. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.
Carballedo A; Amico F; Ugwu I; Fagan AJ; Fahey C; Morris D; Meaney JF; Leemans A; Frodl T
Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):537-48. PubMed ID: 22585743
[TBL] [Abstract][Full Text] [Related]
16. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.
Chepenik LG; Fredericks C; Papademetris X; Spencer L; Lacadie C; Wang F; Pittman B; Duncan JS; Staib LH; Duman RS; Gelernter J; Blumberg HP
Neuropsychopharmacology; 2009 Mar; 34(4):944-51. PubMed ID: 18704093
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
Szeszko PR; Lipsky R; Mentschel C; Robinson D; Gunduz-Bruce H; Sevy S; Ashtari M; Napolitano B; Bilder RM; Kane JM; Goldman D; Malhotra AK
Mol Psychiatry; 2005 Jul; 10(7):631-6. PubMed ID: 15768049
[TBL] [Abstract][Full Text] [Related]
18. Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.
Hajek T; Kopecek M; Höschl C
World J Biol Psychiatry; 2012 Mar; 13(3):178-87. PubMed ID: 21722019
[TBL] [Abstract][Full Text] [Related]
19. Effect of BDNF Val66Met on hippocampal subfields volumes and compensatory interaction with APOE-ε4 in middle-age cognitively unimpaired individuals from the ALFA study.
Vilor-Tejedor N; Operto G; Evans TE; Falcon C; Crous-Bou M; Minguillón C; Cacciaglia R; Milà-Alomà M; Grau-Rivera O; Suárez-Calvet M; Garrido-Martín D; Morán S; Esteller M; Adams HH; Molinuevo JL; Guigó R; Gispert JD;
Brain Struct Funct; 2020 Nov; 225(8):2331-2345. PubMed ID: 32804326
[TBL] [Abstract][Full Text] [Related]
20. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
